This story improves upon other recent Fox News efforts by including an independent expert perspective — the lack of which we commented on in a blog post about Fox News last week. But while our star score reflects that improvement, we still don’t think this story contributes very much to the public dialogue about health care. Our concerns are detailed in the review.
A study finds lower rates of gestational diabetes, but also more small babies, stillbirths, and newborn deaths in women who had bariatric surgery prior to their pregnancies compared with obese women who didn’t have surgery.
A generally complete report on a study of peer phone counseling for postpartum depression.
Many consumers and health care providers continue to hope that a pill, including a seemingly harmless one like vitamin D, will be the solution to a host of chronic diseases. This story explains why that thinking has a lot of holes in it.
This was a report on a Finnish study about the potential cardiovascular benefits of frequent sauna use. Read our review before you commit to a daily sit in the sweat lodge.
A “peanut patch” eliminates allergic reactions to small amounts of peanut protein in about half of the participants in an experimental study presented at a conference. While the overall story is solid, we think it’s important to notify readers of the limited peer review that such conference presentations receive. We offer a primer on this topic here.
This story takes as a given that the drug being discussed is 92% effective for preventing HIV infections. Exploring that statistic would have uncovered some fundamental concerns about the value of this treatment approach.
Our review offers a few suggestions for how this story could have been improved, but honestly, we couldn’t come up with much.
This story carefully characterized the participants enrolled in a Pfizer-sponsored smoking cessation study that involved the drug Chantix. And for that reason, we’d give it a slight edge over a competing New York Times piece on the same study. Both stories were well written and delivered a useful summary of the research.
This was an informative and engaging summary in which we were pleased to see cost information — a feature missing from a competing Reuters story. But we think the headline could mislead readers about the true scope of the drug’s potential benefits.